Cord Blood America (CBAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 240 | -2,979 | -3,495 | -6,510 | -8,452 |
| Depreciation Amortization | 539 | 1,810 | 1,859 | 2,369 | 1,476 |
| Accounts receivable | -177 | -21 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 24 | -90 | N/A | N/A | N/A |
| Other Working Capital | 481 | 407 | -219 | 858 | -883 |
| Other Operating Activity | -328 | 259 | 1,937 | 1,766 | 3,475 |
| Operating Cash Flow | $780 | $-614 | $82 | $-1,517 | $-4,384 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -46 | -7 | -309 | -315 | -176 |
| Net Acquisitions | N/A | N/A | N/A | N/A | 135 |
| Other Investing Activity | -75 | 0 | -94 | -632 | -425 |
| Investing Cash Flow | $-121 | $-7 | $-403 | $-947 | $-466 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 2,200 | N/A |
| Debt Issued | N/A | N/A | 1,545 | N/A | 4,160 |
| Debt Repayment | -100 | N/A | N/A | N/A | N/A |
| Common Stock Issued | N/A | N/A | N/A | 512 | 450 |
| Other Financing Activity | 0 | 0 | -1,118 | 0 | -129 |
| Financing Cash Flow | $-100 | $N/A | $427 | $2,712 | $4,481 |
| Exchange Rate Effect | N/A | N/A | 109 | N/A | N/A |
| Beginning Cash Position | 709 | 394 | 182 | 332 | 717 |
| End Cash Position | 751 | 709 | 394 | 182 | 347 |
| Net Cash Flow | $42 | $315 | $212 | $-151 | $-369 |
| Free Cash Flow | |||||
| Operating Cash Flow | 780 | -614 | 82 | -1,517 | -4,384 |
| Capital Expenditure | -46 | -7 | -309 | -315 | -176 |
| Free Cash Flow | 734 | -620 | -228 | -1,832 | -4,560 |